000 01534 a2200409 4500
005 20250518070028.0
264 0 _c20210201
008 202102s 0 0 eng d
022 _a1432-198X
024 7 _a10.1007/s00467-019-04400-w
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBacchetta, Justine
245 0 0 _aTreatment of hyperphosphatemia: the dangers of high PTH levels.
_h[electronic resource]
260 _bPediatric nephrology (Berlin, Germany)
_c03 2020
300 _a493-500 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aCalcimimetic Agents
_xadministration & dosage
650 0 4 _aCardiovascular Diseases
_xetiology
650 0 4 _aChild
650 0 4 _aChronic Kidney Disease-Mineral and Bone Disorder
_xblood
650 0 4 _aClinical Decision-Making
650 0 4 _aConsensus
650 0 4 _aHumans
650 0 4 _aHyperparathyroidism, Secondary
_xblood
650 0 4 _aHyperphosphatemia
_xblood
650 0 4 _aNephrology
_xstandards
650 0 4 _aParathyroid Hormone
_xblood
650 0 4 _aPediatrics
_xstandards
650 0 4 _aPhosphates
_xblood
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aReference Values
650 0 4 _aRenal Dialysis
_xadverse effects
650 0 4 _aTreatment Outcome
650 0 4 _aVitamin D
_xadministration & dosage
773 0 _tPediatric nephrology (Berlin, Germany)
_gvol. 35
_gno. 3
_gp. 493-500
856 4 0 _uhttps://doi.org/10.1007/s00467-019-04400-w
_zAvailable from publisher's website
999 _c30282801
_d30282801